Baxter (NYSE:BAX) has closed an offering of senior notes worth approximately $1.68 billion (EU €1.5 billion), according to a recently posted SEC filing. The Deerfield, Ill.-based company said that it offered $841.3 million (EU €750 million) in 0.4% senior notes due 2024 and $841.3 million (EU €750 million) in 1.3% senior notes due 2029. The senior notes […]
Mom knows best: How mothers inspired medtech’s top CEOs
On Sunday, we Americans honor our mothers. The flowers, brunches, jewelry and other tokens can’t come close to repaying the women who raised us, fed us, tended our wounds, cleaned up our messes, made us clean up our own, and taught us how to be in the world. Business leaders often talk about their fathers’ […]
DaVita taps Javier Rodriguez as CEO | Personnel Moves – April 29, 2019
DaVita Healthcare (NYSE:DVA) said today that its board of directors unanimously elected Javier Rodriguez to succeed Kent Thiry as its new CEO, effective June 1. The Denver-based company said that former CEO Thiry will transition to serve as executive chairman of the board, and that the announcement comes as part of a multi-year succession planning process. […]
Baxter shares dip despite Q1 earnings beat
Shares in Baxter (NYSE:BAX) fell today despite the medical device maker beating expectations on Wall Street with its first quarter 2019 earnings results. The Deerfield, Ill.-based company posted profits of $347 million, or 66¢ per share, on sales of approximately $2.63 billion for the three months ended March 31, seeing the bottom line shrink 10.8% while […]
ConvaTec taps Bitar as CEO | Personnel Moves – March 26, 2019
ConvaTec (LON:CTEC) said today it tapped Karim Bitar as its new CEO, set to take the position on September 30. Prior to joining the U.K.-based medtech company, Bitar served as CEO of agricultural biotech company Genus, holding the corner office position for approximately eight years. Before his time with Genus, Bitar spent 15 years in various […]
Baxter, Biomérieux ink acute kidney injury biomarker dev deal
Baxter (NYSE:BAX) said today that it inked a partnership deal with Biomérieux looking to develop biomarkers to identify acute kidney injury. The partnership was announced at the International Symposium on Intensive Care and Emergency Medicine, Deerfield, Ill.-based Baxter said. Both companies said they hope to develop the biomarkers to help rapidly identify and inform treatment of acute […]
Baxter cleared from DoJ antitrust saline probe
Baxter (NYSE:BAX) said yesterday that it has been cleared from a U.S. Dept. of Justice antitrust probe, launched in 2017, investigating companies that market intravenous saline solutions. The probe came as hospitals endured a shortage of intravenous saline solutions, which are used to hydrate hospital patients. The shortage dates back to late 2013, after drugmakers told […]
Baxter acquires software developer True Process
Baxter (NYSE:BAX) said last week that it acquired healthcare software developer True Process. The company’s Vines software platform is designed for bedside data collection and normalization, according to a report from BizTimes. Founder Todd Dunsirn, who reportedly left the firm after the acquisition closed, told BizTimes that the company’s software aims to connect the various devices […]
Baxter launches on-demand peritoneal dialysis solution device trial
Baxter (NYSE:BAX) said yesterday that it launched an FDA-cleared clinical trial of its on-demand peritoneal dialysis solution generation system intended to allow patients to make peritoneal dialysis solutions in small batches at home. The system is designed to use a small water filtration device, concentrates and Deerfield, Ill.-based Baxter’s Amia automated peritoneal dialysis system to turn a […]
Analyst downgrades pressure medtech stocks
Several medical device companies took hits yesterday after analysts on Wall Street downgraded their stocks, on a day when the major market indices each closed up a hair, and even medtech firms that enjoyed upgrades came under pressure. Globus Medical (NYSE:GMED) suffered the most after Morgan Stanley analyst David Lewis cut his rating on the stock from […]
Senseonics CFO Elsey to retire | Personnel Moves – December 4, 2018
Senseonics (NYSE:SENS) said yesterday that its CFO R. Elsey is retiring for the company, and that it has begun searching for a permanent replacement. The Germantown, Md.-based company said that Elsey will stay on until a replacement is appointed, and remain on in an advisory role through to the completion of the company’s 2018 fiscal […]
- 1
- 2
- 3
- …
- 27
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube